KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Treasury Shares (2016 - 2025)

Merck (MRK) has disclosed Treasury Shares for 17 consecutive years, with $63.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Treasury Shares rose 8.05% to $63.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $63.0 billion, a 8.05% increase, with the full-year FY2025 number at $63.0 billion, up 8.05% from a year prior.
  • Treasury Shares was $1.1 billion for Q4 2025 at Merck, up from $1.1 billion in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $1.1 billion in Q4 2025 to a low of $3.0 million in Q2 2021.
  • A 5-year average of $844.5 million and a median of $1.0 billion in 2022 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: fell 1.09% in 2022, then grew 8.05% in 2025.
  • Merck's Treasury Shares stood at $57.1 billion in 2021, then fell by 1.09% to $56.5 billion in 2022, then increased by 1.7% to $57.4 billion in 2023, then increased by 1.48% to $58.3 billion in 2024, then increased by 8.05% to $63.0 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Treasury Shares are $63.0 billion (Q4 2025), $61.8 billion (Q3 2025), and $60.5 billion (Q2 2025).